Disease/Infection News

RSS

Experimental model reveals possible causes and treatments for long-COVID

In a recent study published in the journal Science Translational Medicine, researchers characterized long-term pulmonary consequences of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mouse-adapted strain (MA10) infection in BALB/c laboratory mice.

11 Jul 2022

New data on duration of protection afforded by natural SARS-CoV-2 infection

In a recent study posted to the medRxiv* preprint server, researchers investigated the immune protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) natural reinfection.

11 Jul 2022

Immune response after mild COVID

In a recent study posted to the medRxiv* preprint server, researchers in Germany assessed the immunity elicited by a mild severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

10 Jul 2022

Study highlights need to prioritize immunocompromised COVID patients

In a recent Morbidity and Mortality Weekly Report (MMWR) published on the United States Center for Disease Control and Prevention (US-CDC) website, researchers evaluated whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected immunocompromised individuals are at a higher risk of intensive care unit (ICU) admission and death.

10 Jul 2022

Artificial Intelligence-based smartphone app for characterizing stool form

In a recent study published in the American Journal of Gastroenterology, researchers at Cedars-Sinai Medical Center in the United States evaluated an artificial intelligence (AI)-based smartphone application (app) trained to assess a patient's stool characteristics.

10 Jul 2022

CDC posts investigation notice about multistate outbreak of Listeria infections

A CDC Investigation Notice regarding a multistate outbreak of Listeria infections has been posted: Listeria Outbreak | CDC.Listeria Outbreak | CDC

10 Jul 2022

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according to a study published July 8 in The Lancet Respiratory Medicine.

8 Jul 2022

Universal influenza B vaccine confers robust and sustained cross-immune protection

A new universal flu vaccine protects against influenza B viruses, offering broad defense against different strains and improved immune protection, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.

8 Jul 2022

Researchers analyze acute and post-acute COVID-19 presentations in athletes

Researchers at the University of São Paulo (USP) in Brazil analyzed data from 43 scientific articles describing the effects of COVID-19 on athletes and concluded that while the disease was asymptomatic or mild in the vast majority of cases (94%), about 8% of the subjects concerned had persistent symptoms affecting their performance and potentially preventing a return to training and competing.

8 Jul 2022

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

Scientists recently conducted a study on community-dwelling adults to determine the prevalence and risk factors of long-term cardiovascular symptoms in COVID-19 recovered individuals.

8 Jul 2022

What is the long-term vaccine effectiveness against SARS-CoV-2 infection?

A new study aimed to estimate the waning of vaccine protection by performing a systematic literature review of studies that reported VE at different times post-vaccination.

8 Jul 2022

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

A recent study reported that long COVID in mice causes brain inflammation and cognitive impairment.

8 Jul 2022

Vaccine and testing delays for monkeypox echo failures in early covid response

Andy Stone is one of the lucky ones. The New York City resident saw a tweet from a local AIDS activist saying that monkeypox vaccines would be available that day at a clinic in Manhattan

8 Jul 2022

The replicative ability and pathogenicity of Omicron BA.4 and BA.5 isolates in hamsters

Researchers characterized the clinical isolates of SARS-CoV-2 Omicron BA.4 and BA.5.

8 Jul 2022

The putative impact of vitamin D receptor gene polymorphisms on SARS-CoV-2 infection among different variants

Researchers assessed the association between SARS-CoV-2 variants and the vitamin D receptor gene.

8 Jul 2022

Study suggests spironolactone may improve clinical outcomes in COVID-19

Researchers performed an integrative analysis of clinical outcomes and viral entry networks in severe COVID-19 infection.

8 Jul 2022

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

Researchers compared the immunogenicity and safety of the protein-based heterodimer vaccine (PHH-1V) and BNT162b2 COVID-19 vaccines.

8 Jul 2022

The strength and breadth of antibody responses elicited by hybrid immunity to COVID-19 vaccination or infection alone

Researchers assessed neutralizing antibody responses to SARS-CoV-2 after receiving one dose of vaccine.

8 Jul 2022

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

A recent study published in the Science journal depicted that mosaic receptor-binding domain (RBD) nanoparticles immunize from diverse sarbecovirus challenges, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), among animal models.

8 Jul 2022

Discovery of multiple new SARS-CoV-2 MPro inhibitors

In a recent study posted to the bioRxiv* preprint server, researchers performed an extensive library docking for new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro) covalent and non-covalent inhibitors.

8 Jul 2022

Disease/Infection News

Experimental model reveals possible causes and treatments for long-COVID

New data on duration of protection afforded by natural SARS-CoV-2 infection

Immune response after mild COVID

Study highlights need to prioritize immunocompromised COVID patients

Artificial Intelligence-based smartphone app for characterizing stool form

CDC posts investigation notice about multistate outbreak of Listeria infections

Monoclonal antibody treatment taken by hospitalized COVID-19 patients reduces mortality

Universal influenza B vaccine confers robust and sustained cross-immune protection

Researchers analyze acute and post-acute COVID-19 presentations in athletes

High prevalence of persistent cardiovascular symptoms in COVID-19 recovered patients according to new study

What is the long-term vaccine effectiveness against SARS-CoV-2 infection?

Characterization of longer-term effects on behavior and brain inflammation following recovery from mild COVID-19

Vaccine and testing delays for monkeypox echo failures in early covid response

The replicative ability and pathogenicity of Omicron BA.4 and BA.5 isolates in hamsters

The putative impact of vitamin D receptor gene polymorphisms on SARS-CoV-2 infection among different variants

Study suggests spironolactone may improve clinical outcomes in COVID-19

Immunogenicity and safety of the protein-based heterodimer booster vaccine for COVID-19

The strength and breadth of antibody responses elicited by hybrid immunity to COVID-19 vaccination or infection alone

Nanoparticle vaccine could protect against animal viruses including future SARS-CoV-2 variants

Discovery of multiple new SARS-CoV-2 MPro inhibitors

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News